Discovery of YFJ-36: Design, Synthesis, and Antibacterial Activities of Catechol-Conjugated β-Lactams against Gram-Negative Bacteria
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c00265 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Fangjun Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Catechols, Microbial Sensitivity Tests, Drug Design. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 92 Literaturangaben. Gefördert von: Youth Innovation Promotion Association of the Chinese Academy of Sciences.
Abstract (Originalsprache)
Cefiderocol is the first approved catechol-conjugated cephalosporin against multidrug-resistant Gram-negative bacteria, while its application was limited by poor chemical stability associated with the pyrrolidinium linker, moderate potency against Klebsiella pneumoniae and Acinetobacter baumannii, intricate procedures for salt preparation, and potential hypersensitivity. To address these issues, a series of novel catechol-conjugated derivatives were designed, synthesized, and evaluated. Extensive structure-activity relationships and structure-metabolism relationships (SMR) were conducted, leading to the discovery of a promising compound 86b (Code no. YFJ-36) with a new thioether linker. 86b exhibited superior and broad-spectrum in vitro antibacterial activity, especially against A. baumannii and K. pneumoniae, compared with cefiderocol. Potent in vivo efficacy was observed in a murine systemic infection model. Furthermore, the physicochemical stability of 86b in fluid medium at pH 6-8 was enhanced. 86b also reduced potential the risk of allergy owing to the quaternary ammonium linker. The improved properties of 86b supported its further research and development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
- School of Pharmacy, University of Chinese Academy of Sciences, No.19A Yuquan Road, Beijing 100049, China.
- Department of Microbiology, Sichuan Primed Bio-Tech Group Co., Ltd., Chengdu, Sichuan Province 610041, P. R. China.
- China Pharmaceutical University, Jiangsu 211198, China.
ORCID-Profile: Yushe Yang
Förderung
- Youth Innovation Promotion Association of the Chinese Academy of Sciences
Zitieren
APA
Liu, F., Kou, Q., Li, H., Cao, Y., Chen, M., Meng, X., Zhang, Y., Wang, T., Wang, H., Zhang, D., & Yang, Y. (2024). Discovery of YFJ-36: Design, Synthesis, and Antibacterial Activities of Catechol-Conjugated β-Lactams against Gram-Negative Bacteria. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c00265
Vancouver
Liu F, Kou Q, Li H, Cao Y, Chen M, Meng X, et al. Discovery of YFJ-36: Design, Synthesis, and Antibacterial Activities of Catechol-Conjugated β-Lactams against Gram-Negative Bacteria. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c00265
BibTeX
@article{Liu2024,
author = {Liu, Fangjun and Kou, Qunhuan and Li, Hongyuan and Cao, Yangzhi and Chen, Meng and Meng, Xin and Zhang, Yinyong and Wang, Ting and Wang, Hui and Zhang, Dan and Yang, Yushe},
title = {Discovery of YFJ-36: Design, Synthesis, and Antibacterial Activities of Catechol-Conjugated β-Lactams against Gram-Negative Bacteria},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c00265}
}
EUVIMED